SCHEMBL28856502

SCHEMBL28856502

CCOC(=O)C1CC1Sc1ccc(-c2ccc(C3CC3)c3ccccc23)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPT P10636 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ APOBEC3A P31941 1/20 0.32
▸ APOBEC3G Q9HC16 1/20 0.32
▸ NR1D1 P20393 1/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ USP30 Q70CQ3 1/20 0.32
▸ ALOX5AP P20292 1/20 0.32
▸ FEN1 P39748 1/20 0.32
▸ CA12 O43570 2/20 0.31
▸ CA1 P00915 2/20 0.31
▸ CA2 P00918 2/20 0.31
▸ CA9 Q16790 2/20 0.31
▸ SLC22A12 Q96S37 1/20 0.31
▸ SLC18A2 Q05940 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28856536 0.94 CYP1A2 (0.35) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856495 0.90 ALOX5AP (0.34) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856521 0.84 SLC22A12 (0.33) CYP1A2CYP2C19SLC22A12
SCHEMBL28856479 0.83 MAPT (0.34) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856544 0.82 MAPT (0.34) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856511 0.81 CA1 (0.35) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856504 0.80 SLC22A12 (0.33) CYP1A2CYP2C19SLC22A12
SCHEMBL28856526 0.80 MAPT (0.32) CYP1A2TSHRCYP2C19MAPTPKM
SCHEMBL28856542 0.79 ALDH1A1 (0.37) MAPTALDH1A1SLC22A12
SCHEMBL28856493 0.78 SLC22A12 (0.38) PKMKDM4EL3MBTL1ALDH1A1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109608432-B Thiophene derivatives as URAT1 inhibitors 江苏艾立康医药科技有限公司 2022-10-11 — — CN disclosed
Send feedback